Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Locoregional Recurrence × exemestane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 88 Neoplasm Metastasis 9 Ovarian Neoplasms 3 Breast Neoplasms, Male 3 Prostatic Neoplasms 2 Obesity 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Carcinoma In Situ 2 Breast Cancer Metastatic 2 Arthralgia 2 Triple Negative Breast Neoplasms 1 Sexuality 1 Recurrence 1 Primary Breast Cancer ER+ve 1 Premenopausal Breast Cancer 1 Pancreatic Neoplasms 1 Pain 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Beast Cancer 1 Locoregional Recurrence 1 Hyperglycemia 1 Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 1 Hormone Receptor Positive Malignant Neoplasm of Breast 1 HER2-positive Breast Cancer 1 First Line Metastatic Breast Cancer 1 Estrogen-receptor Positive Invasive Metastatic Breast Cancer 1 ER+ Breast Cancer 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Diseases 1

Interventions

ribociclib 1 exemestane 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05467891 2026-02-27

RaPhLRR

Hoosier Cancer Research Network

Phase 2 Recruiting

Locoregional Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡